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Abstract Orexin-A and orexin-B are hypothalamic neu-
ropeptides isolated from a small group of neurons in the
hypothalamus, which project their axons to all major parts
of the central nervous system. Despite the extensive
information about orexin expression and function at dif-
ferent parts of the nervous system in adults, data about the
development and maturation of the orexin system in the
brain are a bit contradictory and insufﬁcient. A previous
study has found expression of orexins in the hypothalamus
after postnatal day 15 only, while others report orexins
detection at embryonic stages of brain formation. In the
present study, we investigated the distribution of orexin-A
and orexin-B neuronal cell bodies and ﬁbers in the brain at
three different postnatal stages: 1-week-, 2-week-old and
adult rats. By means of immunohistochemical techniques,
we demonstrated that a small subset of cells in the lateral
hypothalamus, and the perifornical and periventricular
areas were orexin-A and orexin-B positive not only in
2-week-old and adult rats but also in 1-week-old animals.
In addition, orexin-A and orexin-B expressing neuronal
varicosities were found in many other brain regions. These
results suggest that orexin-A and orexin-B play an impor-
tant role in the early postnatal brain development. The
widespread distribution of orexinergic projections through
all these stages may imply an involvement of the two
neurotransmitters in a large variety of physiological and
behavioral processes also including higher brain functions
like learning and memory.
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Introduction
Orexin-A and orexin-B, also named by de Lecea et al.
(1998) as hypocretin one and two (hypothalamic member
of the incretin family of hormones), are neurotransmitters
isolated from small subset of neurons speciﬁcally localized
within and around the lateral hypothalamus (LH), posterior
hypothalamus, dorsomedial hypothalamic nucleus (DMH),
perifornical and subthalamic areas (Gautvik et al. 1996;
Sakurai et al. 1998). The number of orexinergic neurons in
the rat brain has been estimated to be only about 4,000
(Kilduff and Peyron 2000). These neurons express mRNA
for a synthesis of the precursor prepro-orexin, giving rise to
orexin-A and orexin-B, structurally related both to each
other and to the intestinal hormone secretin. Orexin-A is a
33-amino acid peptide the sequence of which is found to be
identical in human, rat, mouse and bovine, while orexin-B
is a 28-amino acid peptide that differs in two amino acids
between the human, rat and mouse sequence (Sakurai et al.
1998).
The brain areas where orexinergic neurons are localized
are known to be involved in the control of food intake
(Anand and Brobeck 1951), but soon after their discovery,
it was found that the orexins play a role also in the
cardiovascular and neuroendocrine systems, energy
homeostasis, thermogenesis, reproduction and locomotor
activity (Lin et al. 1999; Sutcliffe and de Lecea 2000;
Smart and Jerman 2002). Additionally, they were involved
in nociception (Bingham et al. 2001), in the sleep regula-
tion and the pathophysiology of narcolepsy (Chemelli et al.
1999; Lin et al. 1999), and higher brain functions as
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might function as a global activator of brain systems,
perhaps by orchestrating autonomic responses with selec-
tive attention (Hagan et al. 1999; Horvath et al. 1999).
Besides the strong innervation of the hypothalamus, an
extensive extrahypothalamic network of orexin-immuno-
reactive ﬁbers suggests that the orexins may exert a strong
modulatory action on many different brain functions and
supports their description as ‘‘physiological integrators’’
(van den Pol et al. 1998; Mintz et al. 2001).
Despite the extensive information about orexin expres-
sion and function at different parts of the nervous system in
adults, data about the development and maturation of the
orexin system in the brain are a bit contradictory and
insufﬁcient. According to previous studies (de Lecea et al.
1998; van den Pol et al. 2001), orexins are expressed by
embryonic days 18–20. Furthermore, mRNA coding for
orexins is detectable at very low levels by the day of birth,
followed by an increase to the maximum at postnatal day
(PND) 20 (van den Pol et al. 2001). In contrast, as shown by
Yamamoto et al. (2000), orexinergic neurons are not evi-
dent until PND 15. This early postnatal period is critical for
development of independent survival; therefore, a number
of LH functions appear to become active early. Within PND
0–3, LH neurons develop glucosensitivity (Shibata et al.
1982) and respond to sensory stimulations (Fisher and Almi
1984). Orexin might provide part of the subcellular sub-
strate for the complex and integrative role of the LH in
development (van den Pol et al. 2001), and in this respect it
is important whether these early responses coincide with the
orexin system activation. For that reason, we undertook the
present study with the aim of examining the expression of
orexin-A and orexin-B in hypothalamic neurons and their
projections in 1-week, 2-week-old and adult animals in
order to clarify if there is any time-related difference in the
orexin expression pattern. We also made an attempt to give
an overview of the putative orexin functions during these
early postnatal stages in the brain development.
Methods
Animals and Tissue Preparation
Adult Wistar rats (250–359 g b.w.), and rats at PND 7 and
PND 14 (ﬁve animals for each age group) were used in this
study. All housing facilities and procedures used were
supervised and approved by the Animal Care and Use Com-
mittee of the University of Twente, The Netherlands and
Trakia University, Stara Zagora, Bulgaria, and were conso-
nantwiththeguidelinesestablishedbytheNIH.Theratswere
deeply anesthetized with Ether and transcardially perfused,
ﬁrst with heparinized cold 0.9% NaCl (1 U heparin/ml
saline) followed by 4% paraformaldehyde in 0.1 M phos-
phate saline (PBS; pH 7.4). After perfusion, the brains were
removed, blocked and postﬁxed by immersion in the same
ﬁxative solution for 24 h at 4C, and then cryoprotected in
25% sucrose in PBS overnight at 4C before cryosection-
ing. The brains were embedded in TissueTek OCT com-
pound (Miles Inc., Elkhart, NI, USA), frozen, and 30 lm
thick sections were cut in a cryostat at -20C. The sections
were separated into ﬁve series, according to the method
proposed by Guillery and Herrup (1997). After rinsing in
0.1 M PBS, each complete series of one-in-ﬁve frontal
sections, stretching through the entire rostrocaudal dimen-
sion of the brain, were either processed for immunohisto-
chemistry immediately or stored in cryoprotectant solution
at -20C.
Immunocytochemistry
The immunohistochemical staining procedure was per-
formed on free-ﬂoating sections according to the ABC
(avidin–biotin–horseradish peroxidase) method (Hsu et al.
1981). Brieﬂy, specimens were pretreated with a solution
of 1% sodium borohydrate in PBS. Appropriate washes in
PBS followed this and subsequent incubations. A hydrogen
peroxide (0.3% in methanol/PBS for 30 min) was used to
inactivate endogenous peroxidase, and the background was
blocked with 5% normal goat serum (NGS) and 1% bovine
serum albumin (BSA) in 0.5% Triton X-100. Incubation in
primary antibodies (Table 1) was for 20 h at room tem-
perature (RT) and was followed by treatment for 2 h with
biotinilated secondary antibody goat anti-rabbit IgG
(1:500; Jackson ImmunoResearch, West Grove, PA, USA).
The sections were then incubated for 1 h in ABC (1:500;
Vector Labs, Burlingame, CA, USA), and after washing
them ABC complex (Vector, 6.25 ll/ml of each compound
in PBS) was applied. Following rinsing, peroxidase activity
was visualized using 2.4% SG substrate kit (Vector) in PBS
for 5 min at room temperature. To reveal the precise
location of labeled neurons and neuronal projections to the
Table 1 Source and dilution of
the primary antibodies
Antibody Source Host Dilution
Orexin-A (PC362-100UL) Calbiochem, Merck Chemicals, Nottingham Rabbit 1:500
Orexin-B (GTX10982) GeneTex Inc., San Antonio, TX, USA Rabbit 1:1,000
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123cortex, we counterstained them with 0.5% Neutral red
(Sigma, St. Louis, MO, USA). Finally, the sections were
dehydrated in a graded series of alcohols, cleared in xylene
and coverslipped with Entellan (Merck, Darmstadt,
Germany).
Negative controls included sections that were incubated
in the absence of primary antibody or in a presence of
nonimmune normal serum in the same dilution as the pri-
mary antibody, as well as antigen–antibody preabsorption
experiments with the native antigen at 4C for 24 h.
Data Analysis and Photomicrograph Production
For the assessment of orexin-A and orexin-B expression in
the hypothalamus, sections from -0.92 to -5.20 mm
(from Bregma) were selected according to Coggeshall and
Lekan (1996). After immunostaining, images were gener-
ated through 2.59,4 9,1 0 9,2 0 9 and 409 objectives, and
the brain slices were photographed with an AxioCam MRC
digital camera linked to a Zeiss Axioplan 2 research
microscope. All digital images were matched for brightness
in Adobe Photoshop 7.0 software.
Results
Speciﬁcity
No immunoreactivityfor orexin-A or orexin-B was detected
in the tissues when the primary or secondary antibody was
replaced with normal serum (not shown). The immunore-
activity was readily discernible at the light microscopic
level by the presence of a dark-gray immunoreactive
product. Neuronal structures were considered to be immu-
nopositive when their staining was clearly stronger than that
in the background.
Distribution of Orexin-A and Orexin-B
Immunoreactivity
In the brains from all three age groups, nearly all orexin-A
and orexin-B positive cell bodies were found bilaterally,
conﬁned to the lateral hypothalamus at the level of the
median eminence (Fig. 1a). A few labeled neurons were
scattered in the dorsal and dorsomedial hypothalamic areas
adjacent to the 3rd ventricle (Fig. 1b). The size of the
neuronal cell bodies was smaller in 1-week-old animals
(Fig. 2a, b) compared to that in 2-week-old (Fig. 3a, b) or
mature brains (Fig. 4a, b), and their neurites were shorter
and thinner. The orexin-A and orexin-B immunoreactivity
often was asymmetrically expressed within the cell body,
usually on one side of the nucleus (Fig. 2b). In 2-week-old
brains, the immunoreactivity was more evenly distributed
throughout the neuronal perikarya, and the neurites were
better developed (Fig. 3a, b). In the adult brains, the neu-
rons were similar in size and shape, fusiform to spherical,
20–30 lm in diameter and had 2–5 primary dendrites with
few secondary arborizations (Fig. 4a, b). Immunoreactivity
was evenly distributed throughout the somata, excluding
the nucleus.
A dense network of neuronal ﬁbers expressing orexin-A
and orexin-B-immunoreactivity was observed in the LH
(Fig. 5a), paraventricular nucleus (PVN) (Fig. 5b) and
strikingly, in the arcuate nucleus. It was also found in the
adjacent median eminence (Fig. 5c). A fairly high density
of orexin-positive ﬁbers was seen close to the lateral and
3rd ventricles, several of which appeared to be in a close
contact with the ependymal cells lining the ventricles
Fig. 1 Coronal section through the hypothalamus of adult rat labeled
with orexin-B antiserum. a A low magniﬁcation showing orexin-
B-positive neurons distributed bilaterally in the lateral hypothalamic
area. b Higher magniﬁcation of a section immunolabeled for Orexin-A.
A few positive neurons are also seen in the dorsal and dorsomedial
hypothalamic area, near the third ventricle (3 V). Scale bars: a 400 lm;
b 50 lm
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123(Fig. 5b). Some of the orexin-IR ﬁbers protruded into the
lumen of the ventricles or the cerebral aqueduct (Fig. 5d).
Outside the hypothalamus, varicose immunoreactive ﬁbers
were found in brain regions of 1- and 2-week-old animals,
where axons have been described in adult rats. Many of the
ﬁbers had large endings, suggestive of synaptic buttons
(Fig. 6a). Orexin-A and Orexin -B immunoreactive ﬁbers
projected to different sites of the brain, including the cor-
tex, the limbic system, particularly to the hippocampus,
septal nuclei and the brain stem. In the brainstem, abun-
dance of orexin-expressing projections was found in locus
coeruleus, parabrachial (Fig. 7), dorsal raphe nuclei, cen-
tral and lateral gray, while in the adjacent mesencephalic
trigeminal nucleus (MTN) the density of orexin-immuno-
reactive ﬁbers was moderate and varied along the
rostrocaudal extension of the nucleus. It was more dense at
the level of the inferior colliculus and sparse to very spars
in the caudal part of MTN. Orexinergic ﬁbers and terminal
arborizations were found in direct apposition to, or cours-
ing over the surface on MNT neurons of all sizes.
Discussion
In the present study, we demonstrate that a subset of cells
in the LH, the perifornical and paraventricular areas are
orexin-A and orexin-B positive not only in adult rats but
also in 1-week and 2-week-old animals. This ﬁnding is in
consent with some previous observations of other groups
(van den Pol et al. 2001), but it is in contrast with the
Fig. 2 Lateral hypothalamus of 1-week-old rat labeled with orexin-A
(arrows)( a) and orexin-B (b) antisera. Sections were counterstained
with neutral red in order to visualize nonimmunoreactive cells. The
size of the neuronal perikarya is small, and the neurites are not
well developed. The granular reaction product is expressed asym-
metrically, usually on one side of the nucleus. Scale bars: a 30 lm;
b 50 lm
Fig. 3 Frontal sections of the hypothalamus of 2-week-old rat
processed for immunohistochemical detection of orexin-A (a) and
orexin-B (b). The size of the orexinergic neurons is bigger compared
to those in 1-week-old animals (see Fig. 2), and the neurites are better
developed (arrows). The granular immunoreaction product is more
evenly distributed in the cytoplasm. Scale bars:3 0lm
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123results of Yamamoto et al. (2000) who did not observe
orexin-A and orexin-B immunoreactive cells and ﬁbers
before PND 15. The existence of the orexin system at early
postnatal stages, which we demonstrate here, suggests that
orexin-A and orexin-B might be important signaling
molecules for brain development, as it has previously
been shown for GABA and glutamate (Spoerri 1988;
Ben-Ari et al. 1994; Constantine-Paton and Cline 1998;
Hahm et al. 1999). GABA acts as a trophic substance
promoting synaptogenesis or the synaptogenic capacity
(Wolff et al. 1978), as also does glutamate, enhancing
neuritic growth and stabilizing early synapses (Owens and
Kriegstein 2002; Leinekugel 2003).
Orexin-A and orexin-B may take part in the two major
events, which indeed play a signiﬁcant role in neuronal
development: formation of synaptically connected net-
works, regulated by neurotropic and neurotrophic factors
and the emergence of bioelectrical network-wide activity
patterns. In fact, although neurotransmitters are generally
associated with neuronal communication in the mature
brain, many of them have been shown to inﬂuence these
two main aspects of brain development and maturation
(Levitt et al. 1997; Meier et al. 1991; Owens and Kriegstein
2002). In vitro experiments indicated that a rapid synapse
formation begins during the ﬁrst week and reaches its
maximum at day 21, as also does the activity of the net-
work (Van Pelt et al. 2004). This qualitatively mimics the
in vivo time course of development (Romijn et al. 1981;
Van Huizen et al. 1985) and coincides with the appearance
of the orexin-positive structures in the brain during the
early postnatal stages, as we show here, which probably
means that orexins take part in the synaptogenesis.
The neuronal activity is essential for the network for-
mation and brain development in many aspects; especially,
for modulation of the adhesion molecules (Itoh et al. 1995)
and establishment of axonal connections (Penn et al. 1998).
The consolidation of intrinsic connections during early
brain development is possible only if there is synchronous
network activity, which develops in immature neocortical
networks shortly after neurogenesis and disappears before
the onset of experience-dependent plasticity (Malenka and
Nicoll 1997). The synchronous network activity triggers
collective activation of silent synapses, a process that starts
at day 6 and reaches its maximum at day 12 in vivo in rats
(Voigt et al. 2005). As we demonstrate, in the hypothala-
mus of 1-week and 2-week-old rats there are orexinergic
neurons, and despite the fact that they are smaller in size
and their arborizations are not well developed, the elec-
trophysiological studies of other research groups indicate
that orexin-A and orexin-B already have a very strong
excitatory effect (for a review see Cutler et al. 1999; van
den Pol et al. 2001). In young hypothalamic neurons in
vitro (cultured for 2 days), orexin-A and orexin-B increase
postsynaptic activity directly (van den Pol 2001), while in
older neurons (cultured for [14 days) orexins stimulate
synaptic activity indirectly via enhancement of GABA and
glutamate secretion (Gao and van den Pol 2000).
In the mature brain, GABA is the primary inhibitory
transmitter; however, during the early postnatal stages of
development, at the time when orexins begin to enhance
activity, GABA is generally excitatory (Obrietan and van
den Pol 1995; Chen et al. 1996). Thus, an orexin-mediated
increase in the release of GABA and glutamate during
early development might enhance excitatory postsynaptic
Fig. 4 Close-up of the lateral hypothalamus of adult rat. a Orexin-A-
immunoreactive neuronal pericarya and varicose neuronal ﬁbers
located in the perifornical area. The cell somata are well developed
and two major types of neurons are well distinguishable: spindle-
shaped neurons (thin arrows) with two main neurites arising from the
opposite poles of the cell body, and multipolar neurons (thick arrows)
with several major neurites emerging from a stellate-shaped soma. F,
fornix. (b) Higher magniﬁcation of orexin-B positive neurons. A
primary dendrite is indicated with thick arrow, and thin arrows are
pointing to two secondary arborizations. Scale bars: a 50 lm;
b 30 lm
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123activity indirectly through these two classical neurotrans-
mitters (van den Pol et al. 2001) and thereby orexin-A and
orexin-B may stimulate the network formation and cell-to-
Fig. 5 Orexin-A and -B expressing neuronal ﬁbers projecting to
different parts of the brain of adult rat. a A dense network of orexin-A
containing axonal varicosities (arrows) in the LH. b Micrograph
illustrating the proximity of orexin-A positive ﬁbers to the ventricular
system. Some of the neuronal processes (arrows) protrude between
the ependymal cells lining the third ventricle (3 V). c Moderate
density of orexin-B immunolabeled projections (arrows) to the
external part of the median eminence (ME). d Orexin-A reactive
ﬁbers at the level of the mesencephalon. Moderate density of the
labeled varicosities, some of which protrude into the lumen of the
cerebral aqueduct (Aq)( arrows). DMPAG, dorsomedial periaqueduc-
tal gray. Scale bars:3 0lm
Fig. 6 Terminal arborizations of orexin-A-reactive projections to the
cortex, the major island of Calleja (ICjM). Many of them have large
endings suggestive of synaptic buttons (arrows). Scale bar:3 0lm
Fig. 7 Section from the pontine part of the brain stem labeled for
orexin-A. In contrast to the very dense immunoreactive varicose
ﬁbers in the medial parabrachial nucleus (MPB), the adjacent caudal
part of the mesencephalic trigeminal nucleus (MTN) expresses sparse
density. Note that axonal varicosities and terminal button-like dots
(arrows) are in close apposition to the MTN neuronal perikarya. Scale
bar:3 0lm
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123cell interactions. Orexins may inﬂuence the early postnatal
development and activity also via stimulation of neuronal
plasticity, which depends on different neurotrophic factors
(Lewin and Barde 1996); especially, brain-derived neuro-
trophic factor (BDNF) and neurotrophin-3 (NT-3) (Thoe-
nen 2000). In a recent study on cultured cortical neurons,
Yamada et al. (2009) demonstrated that chronic application
of orexins signiﬁcantly up-regulates the expression of NT-3
mRNA.
We found early postnatal orexin-IR axons in all medial
and lateral regions of the hypothalamus, which suggests
that orexin may exert not only a local feedback upon the
neurons in the region where these neurotransmitters are
synthesized, but also may play a role in the general mod-
ulation of a number of hypothalamic functions, which is in
consent with the results of van den Pol et al. (1998).
We detected the densest arborization of orexinergic
axons in the brain stem in the locus coeruleus (LC). The
LC noradrenergic system gives rise to most of norepi-
nephrine projections to all brain regions (Astor-Jones
et al. 1995) and has directly been tied to a variety of brain
functions, including the sleep–wake cycle, attention,
learning and memory (Jouvet 1969; Robbins 1984; Sara
and Devauges 1988). The particularly strong orexinergic
innervation of LC, which we reveal in our investigation,
underscores the potentially strong role that orexins might
play in enhancing the activity of the LC noradrenergic
system and entails orexins in the control of arousal and
attention. In this respect, our ﬁndings in rat correspond
well to the conclusions of Peyron et al. (2000) and
Thannickal et al. (2000) that orexins are involved in the
pathogenesis of sleep disorders such as narcolepsy-cata-
plexy in humans.
Unlike the results of van den Pol et al. (1998), we
observed a relatively well-expressed orexinergic projec-
tions to the median eminence, as alsoreportedby Chen et al.
(1999). The median eminence represents the anatomical
interface between brain and the anterior pituitary. It is the
ﬁnal point of converge of pathways from the CNS on the
peripheral endocrine system, and thus the orexins could
impinge on this system and alter the release of hormones.
The presence of orexin-A and orexin-B IR ﬁbers in the
MTN, which we show, provides further evidence that the
central orexigenic system of the rat may participate in
the autonomic control of feeding behavior. MTN is a unique
structure, which includes primary sensory neurons inner-
vating the masticatory muscle spindles and mechanore-
ceptors associated with the teeth (for details see Jerge
1963). However, little is known as to whether orexin-A and
orexin-B projections innervate the nucleus (Zhang and Luo
2002; Stoyanova and Lazarov 2005). Our results clearly
demonstrate that MTN receives a direct innervation by both
orexins with somatotopic arrangement. While orexin-B
ﬁbers are more equally distributed, orexin-A-IR projections
are predominantly found in the rostral part of the nucleus
where the perikarya of the muscle spindle afferents are
located. This leads to the conclusion that the hypothalamic
orexin system may inﬂuence both the masticatory and
proprioceptive processes at the level of the MTN.
In summary, the hypothalamic neurons of 1-week-old
rats already express orexin-A and orexin-B IR, which may
imply an involvement of these neurotransmitters in the
brain development and maturation during the early post-
natal stages. Orexins may play this role via different neu-
rotrophic factors and direct or indirect activation of
neuronal network activity. The distribution of orexin-A and
orexin-B IR cell bodies and ﬁbers at early postnatal stages
is similar to that found in adult rat brain and is consistent
with the potential roles for orexins in a wide variety of
physiological and behavioral processes. In addition to the
direct innervation of many targets in the CNS, neuronal
activity of some parts of the brain could also be modulated
by the orexin system indirectly, either via very dense
orexinergic projections to nonspeciﬁc groups of neurons, or
in paracrine manner via the orexins in the cerebro-spinal
ﬂuid, released by the protrusions of orexin-immunoreactive
ﬁbers into the ventricular system of the brain.
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